Evidence Finder

Evidence Finder for Automatic Scientific & Competitive Search

An always-on agent that automatically monitors new scientific publications, clinical evidence and competitor activity. It detects, ranks and turns every relevant finding into a structured report — without a single manual search.

The limitations of manual evidence tracking in life sciences

People still rely on manual processes to find research papers, using alerts, emails, or basic tools as a simple research paper finder. As the volume of research articles continues to grow, manual tracking makes it difficult to connect new publications, understand changes in the scientific evidence landscape, and turn scattered information into actionable knowledge — causing teams to miss important insights and react too late.

Alert-level signals illustration
Alert-level signals

Alerts notify publications, not insights

They inform you that a paper exists, but do not explain what actually changed in the evidence — or whether it matters for your strategy.

Evidence not connected to strategy illustration
Lack of context

Evidence is not connected to strategy

There is no context on competitors, endpoints, or strategic relevance for decision making — only piles of papers and PDFs.

Critical insights hidden in papers illustration
Missed knowledge

Critical insights remain hidden in papers

Evidence is detected, but not transformed into actionable scientific knowledge. The signal is there — nobody has time to read it.

Always-on evidence intelligence, not just alerts

The Evidence Finder monitors 232M+ publications continuously and ranks every new finding by its strategic impact — so your team acts on what matters, not on noise.

app.centivence.com/evidence-finder
Atopic Dermatitis — Evidence Report Search agent · Updated today, 09:14
4 new
Articles with potential impact 26 May 2025
Paper Impact Justification
Long-term efficacy of biologic therapy in moderate-to-severe atopic dermatitis: a 2-year real-world analysis
R. Mäller et al. · Journal of Dermatological Science, 2024
5/5 High impact
Directly supports value dossier — 2-year real-world data showing sustained EASI-75 response strengthens payer arguments for long-term reimbursement approval.
Cost-effectiveness of JAK inhibitors vs biologics in atopic dermatitis: European payer perspective
A. Lindström et al. · PharmacoEconomics, 2024
3/5 Mid impact
Relevant for HTA submissions — European payer ICER thresholds favour biologic class; useful to counter JAK competitor messaging in market access.
Patient-reported outcomes in IL-4/IL-13 inhibitor trials: a meta-analysis across 14 RCTs
S. Okafor, T. Brennan · NEJM Evidence, 2023
1/5 Low impact
→ PRO data consistent with existing evidence. No new differentiation signal vs current competitive messaging on DLQI improvement.
Head-to-head comparison of biologic agents in moderate-to-severe AD: network meta-analysis update
C. Renard, P. Moreau · Lancet Dermatology, 2025
4/5 High impact
Updated NMA with 2025 data — strengthens comparative efficacy narrative and provides new EASI and IGA endpoints to support payer submissions and congresses.

Always-on monitoring

Never miss a relevant publication. The agent runs 24/7, surfacing new evidence the moment it is indexed across all major scientific databases.

Impact-ranked results

Every finding is scored and ranked by strategic relevance, so your team knows what to act on first and what can wait.

Source traceability

Every insight links directly to the exact paragraph and source paper it came from — full audit trail for regulatory and compliance workflows.

Full metadata extraction

Automatically extracts authors, journal, date, DOI, and full PDF content when the paper is open access — no manual data entry.

How our AI Evidence Finder works?

Step 1

Define your scientific context

Provide Centivence with your role, department, products or devices, competitors, and strategic focus. This context allows the Evidence Tracker to understand your priorities and tailor how it finds and evaluates scientific evidence.

Step 2

Set up the automatic evidence search

Define what type of research papers and scientific articles you want to monitor.

The system creates an automatic evidence search that continuously finds, analyzes, and centralizes relevant publications inside your automatic search database.

Step 3

Let the system continuously track new evidence

Once activated, the AI evidence tracker retrieves the most recent publications and keeps monitoring new scientific evidence in real time.

Every new paper detected is automatically added to your evidence table — and to the right basket in your repository — without manual searches or alerts.

Step 4

Identify impact and extract insights faster

Each publication is analyzed by the system using your defined context.

The Evidence Tracker assigns an impact assessment and justification, and compiles them into living reports that help you quickly understand how new evidence affects your strategy and scientific positioning.

What makes Centivence Evidence Tracker unique?

The Evidence Finder is built to identify and interpret scientific evidence the same way expert researchers do, but continuously and at scale. Instead of acting as a simple research paper finder, it transforms new publications into structured knowledge that teams can immediately understand and act on.

Turns evidence into living reports

From each search, the agent can create weekly, biweekly, or monthly newsletters with the information from that search.

What is included in each report depends on the objectives set by the user. The content adapts to the request.

Weekly Evidence Report 4 new
Lebrikizumab · Atopic Dermatitis · 26 May 2025
5/5
2 papers
3/5
1 paper
1/5
1 paper
Key finding
2-year real-world EASI-75 data strengthens payer arguments for long-term reimbursement renewal in EU markets.
High impact Market Access Value dossier

Hyperpersonalized to every team

The same publication can have a different impact score for Medical Affairs, Market Access, or HEOR — because each team has a different strategic context and priorities.

Centivence evaluates every finding through the lens of each team, delivering relevance instead of noise.

Head-to-head NMA: biologics in moderate-to-severe AD — 2025 update
C. Renard et al. · Lancet Dermatology, 2025
Medical Affairs
5/5
Market Access
3/5
HEOR
2/5
Same paper — different impact per team context

Frequently asked questions

Have more questions? Send us an email.

What is an Evidence Tracker?

An Evidence Tracker is a system designed to continuously monitor, collect, and organize scientific publications and research papers. Unlike basic alerts, it helps teams understand how new evidence fits into the broader scientific evidence landscape.

How is an Evidence Tracker different from journal alerts?

Journal alerts simply notify you when a paper is published. An AI Evidence Tracker goes further by evaluating relevance, adding context, and transforming new research into structured and actionable knowledge instead of isolated notifications.

Can the Evidence Tracker automatically find new research papers?

Yes. The Evidence Tracker works as an AI research paper finder, continuously scanning scientific and clinical sources to find research papers in real time, without manual searches or periodic reviews.

What types of research does the Evidence Tracker monitor?

The system monitors peer-reviewed research articles, clinical publications, and scientific evidence relevant to your defined focus areas, such as disease areas, competitors, or technologies.

How does the Evidence Tracker help teams avoid missing important insights?

By continuously tracking new publications and evaluating their relevance, the Evidence Tracker reduces the risk of missing critical messages hidden inside research papers and highlights meaningful changes in the evidence landscape.

Does the Evidence Tracker provide context for new evidence?

Yes. Instead of listing papers, the Evidence Tracker connects new research with existing knowledge, helping teams understand why the evidence matters and how it may impact scientific or strategic positioning.

How often does the Evidence Tracker update?

The Evidence Tracker updates every day. It continuously scans scientific and clinical sources on a daily basis, detecting new research papers as soon as they are published and adding them to your evidence tracking workflow automatically. This daily periodicity ensures teams stay up to date with the latest scientific evidence, without relying on weekly alerts or manual searches.

Who typically uses an Evidence Tracker?

Evidence Trackers are commonly used by Medical Affairs, Market Access, HEOR, Competitive Intelligence, and research teams that need to continuously follow and interpret scientific evidence to support informed decision making.

Stop managing evidence.
Start using it.

See how Centivence gives your Medical Affairs, Marketing, and Market Access teams a single system to find, organise, and act on scientific evidence.

Book a demo